Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or primary clinical data
PubMed 32867258 · doi:10.3390/nu12092616
What was done
This narrative review examined the historical and modern therapeutic application of the ketogenic diet and its modified variants (modified Atkins diet, low-glycemic-index treatment) for refractory epilepsy, discussing metabolic mechanisms and clinical implementation.
What was found
The abstract reports no numerical outcomes, patient counts, or effect sizes. It qualitatively states that the ketogenic diet offers protection against seizures in difficult-to-treat epilepsy, alters biochemical pathways by deriving energy primarily from fat instead of carbohydrates, and restores brain metabolic homeostasis.
Why it matters
Metabolic dietary therapy represents an important non-pharmacologic option for epilepsy management when standard anti-seizure medications fail.
Limits
The abstract provides no empirical data, statistical findings, or description of systematic literature search criteria. Specific implementation barriers and exact mechanisms of action were not quantified or detailed.
Cited by
- supports The modified Atkins diet consists of approximately 65% to 70% fat, 20% to 30% protein, and no more than 5% to 10% carbohydrates.